FMC Corporation Initiates Litigation Against Summit Agro For Patent Infringement Of Sulfentrazone Herbicide
PHILADELPHIA, Jan. 16, 2014 /PRNewswire/ -- FMC Corporation (NYSE: FMC) initiated litigation today against Summit Agro LLC and Summit North American Holdings Corporation in United States District Court in Wilmington, Del., seeking injunctive and monetary relief for Summit's infringement of an FMC patent covering production of FMC's sulfentrazone herbicide, which is marketed in the United States under the Spartan® and Authority® brands. The complaint also alleges that Summit has engaged in unfair competition.
"FMC has invested significantly in developing sulfentrazone and associated production technology, as well as in establishing the strong reputation of Spartan and Authority brands in the minds of our customers," said Marc Hullebroeck, North America and EMEA vice president and business director, FMC Agricultural Solutions. "FMC will vigorously defend its intellectual property rights."
FMC Corporation is a diversified chemical company serving agricultural, industrial, environmental, and consumer markets globally for more than a century with innovative solutions, applications and quality products. In 2012, FMC had annual sales of approximately $3.4 billion. The company employs approximately 6,000 people throughout the world, and operates its businesses in three segments: FMC Agricultural Solutions, FMC Health and Nutrition and FMC Minerals. For more information, visit www.FMC.com.
Safe Harbor Statement under the Private Securities Act of 1995: Statements in this news release that are forward-looking statements are subject to various risks and uncertainties concerning specific factors described in FMC Corporation's 2012 Form 10-K and other SEC filings. Such information contained herein represents management's best judgment as of the date hereof based on information currently available. FMC Corporation does not intend to update this information and disclaims any legal obligation to the contrary. Historical information is not necessarily indicative of future performance.
SOURCE FMC Corporation